Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Exp Med. 2005 May 16;201(10):1523-30. Epub 2005 May 9.

Decay-accelerating factor modulates induction of T cell immunity.

Author information

  • 1Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Abstract

Decay-accelerating factor (Daf) dissociates C3/C5 convertases that assemble on host cells and thereby prevents complement activation on their surfaces. We demonstrate that during primary T cell activation, the absence of Daf on antigen-presenting cells (APCs) and on T cells enhances T cell proliferation and augments the induced frequency of effector cells. The effect is factor D- and, at least in part, C5-dependent, indicating that local alternative pathway activation is essential. We show that cognate T cell-APC interactions are accompanied by rapid production of alternative pathway components and down-regulation of Daf expression. The findings argue that local alternative pathway activation and surface Daf protein function respectively as a costimulator and a negative modulator of T cell immunity and explain previously reported observations linking complement to T cell function. The results could have broad therapeutic implications for disorders in which T cell immunity is important.

PMID:
15883171
[PubMed - indexed for MEDLINE]
PMCID:
PMC2212927
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk